Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Biomedical Materials Research|August 1, 1994
Evaluation of a series of tyrosine-derived polycarbonates as degradable biomaterialsS I Ertel, J KohnExpert Opinion on Investigational Drugs|May 1, 1997
Mibefradil (Ro 40-5967): the first selective T-type Ca2+ channel blockerS I Ertel, J P ClozelTrends in Pharmacological Sciences|February 1, 1997
Low-voltage-activated T-type Ca2+ channelsS I Ertel, E A ErtelJournal of Biomedical Materials Research|December 1, 1990
Radiofrequency plasma deposition of oxygen-containing films on polystyrene and poly(ethylene terephthalate) substrates improves endothelial cell growthS I Ertel, B D Ratner, T A HorbettProceedings of the Association of American Physicians|October 16, 1999
Voltage-gated T-type Ca2+ channels and heart failureJ P Clozel, E A Ertel, S I ErtelJournal of Molecular Medicine (Berlin, Germany)|June 3, 1999
Endothelin antagonism with bosentan: a review of potential applicationsS Roux, V Breu, S I Ertel, et al.Cardiovascular Drugs and Therapy|March 26, 1998
T-type Ca2+ channels and pharmacological blockade: potential pathophysiological relevanceS I Ertel, E A Ertel, J P ClozelExpert Opinion on Investigational Drugs|July 5, 2005
The pharmacology of bosentanV Breu, S I Ertel, S Roux, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 3, 1998
Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blockerJ P Clozel, E A Ertel, S I ErtelJournal of Biomedical Materials Research|November 1, 1995
Evaluation of poly(DTH carbonate), a tyrosine-derived degradable polymer, for orthopedic applicationsS I Ertel, J Kohn, M C Zimmerman, et al.Pageof 2